8 results on '"Blom EW"'
Search Results
2. Hox genes polymorphism depicts developmental disruption of common sole eggs
- Author
-
Kavouras Menelaos, Malandrakis Emmanouil E., Danis Theodoros, Blom Ewout, Anastassiadis Konstantinos, Panagiotaki Panagiota, and Exadactylos Athanasios
- Subjects
egg quality ,embryonic development ,hox genes ,polymorphism ,reproduction ,Biology (General) ,QH301-705.5 - Abstract
In sole aquaculture production, consistency in the quality of produced eggs throughout the year is unpredictable. Hox genes have a crucial role in controlling embryonic development and their genetic variation could alter the phenotype dramatically. In teleosts genome duplication led paralog hox genes to become diverged. Direct association of polymorphism in hoxa1a, hoxa2a & hoxa2b of Solea solea with egg viability indicates hoxa2b as a potential genetic marker. High Resolution Melt (HRM) analysis was carried out in 52 viable and 61 non-viable eggs collected at 54±6 hours post fertilization (hpf). Allelic and genotypic frequencies of polymorphism were analyzed and results illustrated a significantly increased risk for non-viability for minor alleles and their homozygous genotypes. Haplotype analysis demonstrated a significant recessive effect on the risk of non-viability, by increasing the odds of disrupting embryonic development up to three-fold. Phylogenetic analysis showed that the paralog genes hoxa2a and hoxa2b, are separated distinctly in two clades and presented a significant ω variation, revealing their diverged evolutionary rate.
- Published
- 2019
- Full Text
- View/download PDF
3. Performance of BRCA1/2 mutation prediction models in male breast cancer patients.
- Author
-
Moghadasi S, Grundeken V, Janssen LAM, Dijkstra NH, Rodríguez-Girondo M, van Zelst-Stams WAG, Oosterwijk JC, Ausems MGEM, Oldenburg RA, Adank MA, Blom EW, Ruijs MWG, van Os TAM, van Deurzen CHM, Martens JWM, Schroder CP, Wijnen JT, Vreeswijk MPG, and van Asperen CJ
- Subjects
- Breast Neoplasms diagnosis, Breast Neoplasms genetics, Breast Neoplasms, Male diagnosis, Cohort Studies, Female, Gene Frequency, Heterozygote, Humans, Male, Ovarian Neoplasms diagnosis, Ovarian Neoplasms genetics, ROC Curve, BRCA1 Protein genetics, BRCA2 Protein genetics, Breast Neoplasms, Male genetics, Genetic Predisposition to Disease genetics, Genetic Testing methods, Mutation
- Abstract
To establish whether existing mutation prediction models can identify which male breast cancer (MBC) patients should be offered BRCA1 and BRCA2 diagnostic DNA screening, we compared the performance of BOADICEA (Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm), BRCAPRO (BRCA probability) and the Myriad prevalence table ("Myriad"). These models were evaluated using the family data of 307 Dutch MBC probands tested for BRCA1/2, 58 (19%) of whom were carriers. We compared the numbers of observed vs predicted carriers and assessed the Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) for each model. BOADICEA predicted the total number of BRCA1/2 mutation carriers quite accurately (observed/predicted ratio: 0.94). When a cut-off of 10% and 20% prior probability was used, BRCAPRO showed a non-significant better performance (observed/predicted ratio BOADICEA: 0.81, 95% confidence interval [CI]: [0.60-1.09] and 0.79, 95% CI: [0.57-1.09], vs., Brcapro: 1.02, 95% CI: [0.75-1.38] and 0.94, 95% CI: [0.68-1.31], respectively). Myriad underestimated the number of carriers in up to 69% of the cases. BRCAPRO showed a non-significant, higher AUC than BOADICEA (0.798 vs 0.776). Myriad showed a significantly lower AUC (0.671). BRCAPRO and BOADICEA can efficiently identify MBC patients as BRCA1/2 mutation carriers. Besides their general applicability, these tools will be of particular value in countries with limited healthcare resources., (© 2017 The Authors. Clinical Genetics published by John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
4. Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence.
- Author
-
Tan-Sindhunata MB, Mathijssen IB, Smit M, Baas F, de Vries JI, van der Voorn JP, Kluijt I, Hagen MA, Blom EW, Sistermans E, Meijers-Heijboer H, Waisfisz Q, Weiss MM, and Groffen AJ
- Subjects
- Alleles, Amino Acid Sequence, Arthrogryposis diagnosis, Arthrogryposis pathology, Base Sequence, Female, Fetus, Gene Expression, Gene Frequency, Genes, Lethal, Genetic Testing, Homozygote, Humans, Male, Molecular Sequence Data, Motor Endplate pathology, Muscle Cells metabolism, Muscle Cells pathology, Netherlands, Pedigree, Prenatal Diagnosis, Primary Cell Culture, Receptors, Cholinergic chemistry, Arthrogryposis genetics, Founder Effect, Motor Endplate genetics, Mutation, Receptor Protein-Tyrosine Kinases genetics, Receptors, Cholinergic genetics
- Abstract
Fetal akinesia deformation sequence (FADS) refers to a clinically and genetically heterogeneous group of disorders with congenital malformations related to impaired fetal movement. FADS can result from mutations in CHRNG, CHRNA1, CHRND, DOK7 and RAPSN; however, these genes only account for a minority of cases. Here we identify MUSK as a novel cause of lethal FADS. Fourteen affected fetuses from a Dutch genetic isolate were traced back to common ancestors 11 generations ago. Homozygosity mapping in two fetuses revealed MUSK as a candidate gene. All tested cases carried an identical homozygous variant c.1724T>C; p.(Ile575Thr) in the intracellular domain of MUSK. The carrier frequency in the genetic isolate was 8%, exclusively found in heterozygous carriers. Consistent with the established role of MUSK as a tyrosine kinase that orchestrates neuromuscular synaptogenesis, the fetal myopathy was accompanied by impaired acetylcholine receptor clustering and reduced tyrosine kinase activity at motor nerve endings. A functional assay in myocytes derived from human fetuses confirmed that the variant blocks MUSK-dependent motor endplate formation. Taken together, the results strongly support a causal role of this founder mutation in MUSK, further expanding the gene set associated with FADS and offering new opportunities for prenatal genetic testing.
- Published
- 2015
- Full Text
- View/download PDF
5. A recurrent deletion syndrome at chromosome bands 2p11.2-2p12 flanked by segmental duplications at the breakpoints and including REEP1.
- Author
-
Stevens SJ, Blom EW, Siegelaer IT, and Smeets EE
- Subjects
- Adolescent, Alleles, Child, Preschool, DNA Copy Number Variations, Developmental Disabilities genetics, Female, Genome-Wide Association Study, Homologous Recombination, Humans, Intellectual Disability genetics, Male, Membrane Proteins genetics, Nerve Tissue Proteins genetics, Oligonucleotide Array Sequence Analysis, Phenotype, alpha Catenin genetics, Chromosomes, Human, Pair 2 genetics, Membrane Transport Proteins genetics, Segmental Duplications, Genomic, Sequence Deletion
- Abstract
We identified an identical and recurrent 9.4-Mbp deletion at chromosome bands 2p11.2-2p12, which occurred de novo in two unrelated patients. It is flanked at the distal and proximal breakpoints by two homologous segmental duplications consisting of low copy repeat (LCR) blocks in direct orientation, which have >99% sequence identity. Despite the fact that the deletion was almost 10 Mbp in size, the patients showed a relatively mild clinical phenotype, that is, mild-to-moderate intellectual disability, a happy disposition, speech delay and delayed motor development. Their phenotype matches with that of previously described patients. The 2p11.2-2p12 deletion includes the REEP1 gene that is associated with spastic paraplegia and phenotypic features related to this are apparent in most 2p11.2-2p12 deletion patients, but not in all. Other hemizygous genes that may contribute to the clinical phenotype include LRRTM1 and CTNNA2. We propose a recurrent but rare 2p11.2-2p12 deletion syndrome based on (1) the identical, non-random localisation of the de novo deletion breakpoints in two unrelated patients and a patient from literature, (2) the patients' phenotypic similarity and their phenotypic overlap with other 2p deletions and (3) the presence of highly identical LCR blocks flanking both breakpoints, consistent with a non-allelic homologous recombination (NAHR)-mediated rearrangement.
- Published
- 2015
- Full Text
- View/download PDF
6. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
- Author
-
Hermans MC, Merkies IS, Laberge L, Blom EW, Tennant A, and Faber CG
- Subjects
- Adolescent, Adult, Aged, Fatigue complications, Fatigue physiopathology, Female, Humans, Male, Middle Aged, Myotonic Dystrophy complications, Severity of Illness Index, Surveys and Questionnaires, Fatigue diagnosis, Myotonic Dystrophy physiopathology, Sleep physiology, Symptom Assessment methods
- Abstract
Introduction: Fatigue and excessive daytime sleepiness are frequent complaints in myotonic dystrophy type 1 (DM1) that often overlap. We aimed to construct a combined fatigue and daytime sleepiness rating scale for DM1 using the Rasch measurement model., Methods: Questionnaires, including the Epworth sleepiness scale, fatigue severity scale, and daytime sleepiness scale, were completed by 354 patients. Data were subjected to Rasch analyses and tested for required measurement issues such as appropriate response categories, absence of item bias, local independence, and unidimensionality., Results: The initial 22 items did not meet Rasch model expectations. After rescoring and removing misfitting items, the final 12-item scale showed good model fit and unidimensionality. High internal consistency (person separation index = 0.80) and validity were demonstrated., Conclusions: The Rasch-built Fatigue and Daytime Sleepiness Scale, developed specifically for DM1 patients, provides interval measures on a single continuum. Its use is suggested for future clinical trials and therapeutic follow-up., (Copyright © 2012 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
7. [Small fibre neuropathy: knowledge is power].
- Author
-
Hoeijmakers JG, Bakkers M, Blom EW, Drenth JP, Merkies IS, and Faber CG
- Subjects
- Diagnostic Techniques, Neurological, Humans, Mutation, Neural Conduction, Pain prevention & control, Peripheral Nervous System Diseases genetics, Peripheral Nervous System Diseases therapy, Sensation Disorders genetics, Sensation Disorders therapy, Sensory Thresholds, Thermosensing, Nerve Fibers pathology, Pain etiology, Peripheral Nervous System Diseases diagnosis, Sensation Disorders diagnosis
- Abstract
Small fibre neuropathy is a neuropathy of the small non-myelinated C-fibres and myelinated Aδ-fibres. Clinically, an isolated small fibre neuropathy is distinguished by sensory and autonomic symptoms, with practically no abnormalities on neurological examination other than possible distorted pain and temperature sensation. Specific diagnostic tests for small fibre neuropathy are skin biopsy, including a count of the intra-epidermal small nerve fibres that cross the basal membrane, and quantitative sensory and autonomic testing. Diabetes mellitus is the most frequent underlying cause of small fibre neuropathy. Other causes can be classified into the following categories: toxic (e.g. alcohol), metabolic, immune-mediated, infectious and hereditary. Recently, in a substantial proportion (29%) of a group of patients with idiopathic small fibre neuropathy, a SCN9A gene mutation was demonstrated, which leads to hyperexcitability of the dorsal root ganglion neurons. Treatment of small fibre neuropathy consists of symptomatic pain relief and, if possible, treatment of the underlying cause of the condition.
- Published
- 2012
8. Unique skin changes in a case of Albright hereditary osteodystrophy caused by a rare GNAS1 mutation.
- Author
-
Klaassens M, Blom EW, Schrander JJ, Ris-Stalpers C, Nieuwenhuijzen Kruseman AC, van Steensel MA, and Schrander-Stumpel CT
- Subjects
- Chromogranins, Humans, Infant, Male, Pedigree, Skin pathology, Fibrous Dysplasia, Polyostotic genetics, GTP-Binding Protein alpha Subunits, Gs genetics, Mutation genetics, Pseudohypoparathyroidism genetics
- Abstract
Albright hereditary osteodystrophy (AHO) is a syndrome of short stature, obesity, brachydactyly and subcutaneous calcifications with pseudohypoparathyroidism (PHP; leading to hypocalcaemia, hyperphosphataemia and elevated levels of parathyroid hormone, PTH). It was first described over 60 years ago. Since then, much has been learned about the aetiology of AHO which has been shown to be caused by heterozygous loss-of-function mutations within the GNAS1 gene. GNAS1 is subject to imprinting leading to phenotypic heterogeneity within kindreds with one mutation. Patients with AHO often present with symptoms of hypocalcaemia and/or with subcutaneous calcifications. The latter is thought to be the typical skin abnormality in AHO. We describe a family with AHO and hormone resistance (PHP type Ia) resulting from a rare mutation in GNAS1. The proband presented with small subcutaneous calcifications in the helix of the right ear and concentrated in a sharply demarcated zone of subcutaneous and dermal hypoplasia. This abnormality has so far not been described in patients with AHO. We speculate on the mechanism of dermal hypoplasia and resistance to PTH and suggest that subcutanous or dermal hypoplasia might be another feature which can be present in patients with AHO.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.